Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.
K Honda, K Nitta, S Horita, W Yumura… - … official publication of …, 1999 - academic.oup.com
BACKGROUND: Ultra-filtration failure is a serious complication of long-term continuous
ambulatory peritoneal dialysis (CAPD). This complication is related to histological changes of the …
ambulatory peritoneal dialysis (CAPD). This complication is related to histological changes of the …
Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine
…, T Kondo, H Yuasa, H Nakayama, S Horita… - … of Pharmacology and …, 2010 - ASPET
This report describes a potent and selective inhibitor of multidrug and toxin extrusion (MATE)
protein, pyrimethamine (PYR), and examines its effect on the urinary and biliary excretion …
protein, pyrimethamine (PYR), and examines its effect on the urinary and biliary excretion …
Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure
K Honda, K Nitta, S Horita, W Yumura, H Nihei - Nephron, 1996 - karger.com
Vascular changes in the peritoneum were histochemically assessed in patients on continuous
ambulatory peritoneal dialysis (CAPD) with ultrafiltration failure. Light microscopy showed …
ambulatory peritoneal dialysis (CAPD) with ultrafiltration failure. Light microscopy showed …
Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices
…, M Iwaki, Y Shiroyanagi, H Nakayama, S Horita… - … of Pharmacology and …, 2007 - ASPET
Simultaneous use of nonsteroidal anti-inflammatory drugs (NSAIDs), probenecid, and other
drugs has been reported to delay the plasma elimination of methotrexate in patients. …
drugs has been reported to delay the plasma elimination of methotrexate in patients. …
[HTML][HTML] Patients with Epstein–Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease
…, K Ida, K Miura, Y Harita, M Hattori, S Horita… - Kidney international, 2010 - Elsevier
Recent linkage analyses of nondiabetic African-American patients with focal segmental
glomerulosclerosis (FSGS) have identified MYH9, encoding nonmuscle myosin heavy chain IIA (…
glomerulosclerosis (FSGS) have identified MYH9, encoding nonmuscle myosin heavy chain IIA (…
Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and …
…, T Kondo, K Tanabe, H Nakayama, S Horita… - European Journal of …, 2014 - Elsevier
Probe substrates for, and inhibitors of, specific transporters are desired to evaluate quantitatively
the in vivo functions of transporters in humans. Based on published data, adefovir and …
the in vivo functions of transporters in humans. Based on published data, adefovir and …
Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in …
…, K Maeda, T Kondo, H Nakayama, S Horita… - Drug metabolism and …, 2011 - ASPET
The present study investigated prediction of the overall renal tubular secretion and hepatic
clearances of anionic drugs based on in vitro transport studies. The saturable uptake of eight …
clearances of anionic drugs based on in vitro transport studies. The saturable uptake of eight …
The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine
…, H Yuasa, T Kondo, H Nakayama, S Horita… - Drug metabolism and …, 2009 - ASPET
Cimetidine is known to cause drug-drug interactions (DDIs) with organic cations in the kidney,
and a previous clinical study showed that coadministration of cimetidine or probenecid …
and a previous clinical study showed that coadministration of cimetidine or probenecid …
Impact of low‐dose rituximab on splenic B cells in ABO‐incompatible renal transplant recipients
D Toki, H Ishida, S Horita, K Setoguchi… - Transplant …, 2009 - Wiley Online Library
The purpose of this study was to assess the effect of a low‐dose rituximab (RIT) at <375 mg/m
2 on B cells in the spleen and peripheral blood. Five renal transplant recipients received a …
2 on B cells in the spleen and peripheral blood. Five renal transplant recipients received a …
High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma
T Kondo, F Ito, H Nakazawa, S Horita, Y Osaka… - The Journal of …, 2004 - Elsevier
PURPOSE:: The presence and potential role of chemokines in clinical tumors remain poorly
understood. Chemokines are a large family of chemoattractant cytokines with several …
understood. Chemokines are a large family of chemoattractant cytokines with several …